Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 69
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Gastric Cancer ; 27(4): 714-721, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38630317

RESUMEN

BACKGROUND: While dietary salt intake has been linked with gastric cancer risk in Asian studies, findings from Western populations are sparse and limited to case-control studies. Our aim was to evaluate the frequency of adding salt to food at table in relation to gastric cancer risk among UK adults. METHODS: We evaluated associations between the frequency of adding salt to food and the risk of gastric cancer in the UK Biobank (N = 471,144) using multivariable Cox regression. Frequency of adding salt to food was obtained from a touchscreen questionnaire completed at baseline (2006-2010). 24-h urinary sodium excretion was estimated using INTERSALT formulae. Cancer incidence was obtained by linkage to national cancer registries. RESULTS: During a median follow-up period of 10.9 years, 640 gastric cancer cases were recorded. In multivariable models, the gastric cancer risk among participants reporting adding salt to food at table "always" compared to those who responded "never/rarely" was HR = 1.41 (95% CI: 1.04, 1.90). There was a positive linear association between estimated 24-h urinary sodium levels and the frequency of adding salt to food (p-trend <0 .001). However, no significant association between estimated 24-h urinary sodium with gastric cancer was observed (HR = 1.19 (95% CI: 0.87, 1.61)). CONCLUSIONS: "Always adding salt to food" at table was associated with a higher gastric cancer risk in a large sample of UK adults. High frequency of adding salt to food at table can potentially serve as a useful indicator of salt intake for surveillance purposes and a basis for devising easy-to-understand public health messages.


Asunto(s)
Cloruro de Sodio Dietético , Neoplasias Gástricas , Humanos , Neoplasias Gástricas/epidemiología , Masculino , Femenino , Persona de Mediana Edad , Estudios Prospectivos , Cloruro de Sodio Dietético/administración & dosificación , Cloruro de Sodio Dietético/efectos adversos , Adulto , Factores de Riesgo , Anciano , Estudios de Seguimiento , Reino Unido/epidemiología , Encuestas y Cuestionarios , Incidencia
2.
Sensors (Basel) ; 21(8)2021 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-33918951

RESUMEN

Structural cracks are a vital feature in evaluating the health of aging structures. Inspectors regularly monitor structures' health using visual information because early detection of cracks on highly trafficked structures is critical for maintaining the public's safety. In this work, a framework for detecting cracks along with their locations is proposed. Image data provided by an unmanned aerial vehicle (UAV) is stitched using image processing techniques to overcome limitations in the resolution of cameras. This stitched image is analyzed to identify cracks using a deep learning model that makes judgements regarding the presence of cracks in the image. Moreover, cracks' locations are determined using data from UAV sensors. To validate the system, cracks forming on an actual building are captured by a UAV, and these images are analyzed to detect and locate cracks. The proposed framework is proven as an effective way to detect cracks and to represent the cracks' locations.

3.
J Neurosci ; 39(11): 2144-2156, 2019 03 13.
Artículo en Inglés | MEDLINE | ID: mdl-30665947

RESUMEN

Neurotrophic factors are candidates for treating epilepsy, but their development has been hampered by difficulties in achieving stable and targeted delivery of efficacious concentrations within the desired brain region. We have developed an encapsulated cell technology that overcomes these obstacles by providing a targeted, continuous, de novo synthesized source of high levels of neurotrophic molecules from human clonal ARPE-19 cells encapsulated into hollow fiber membranes. Here we illustrate the potential of this approach for delivering glial cell line-derived neurotrophic factor (GDNF) directly to the hippocampus of epileptic rats. In vivo studies demonstrated that bilateral intrahippocampal implants continued to secrete GDNF that produced high hippocampal GDNF tissue levels in a long-term manner. Identical implants robustly reduced seizure frequency in the pilocarpine model. Seizures were reduced rapidly, and this effect increased in magnitude over 3 months, ultimately leading to a reduction of seizures by 93%. This effect persisted even after device removal, suggesting potential disease-modifying benefits. Importantly, seizure reduction was associated with normalized changes in anxiety and improved cognitive performance. Immunohistochemical analyses revealed that the neurological benefits of GDNF were associated with the normalization of anatomical alterations accompanying chronic epilepsy, including hippocampal atrophy, cell degeneration, loss of parvalbumin-positive interneurons, and abnormal neurogenesis. These effects were associated with the activation of GDNF receptors. All in all, these results support the concept that the implantation of encapsulated GDNF-secreting cells can deliver GDNF in a sustained, targeted, and efficacious manner, paving the way for continuing preclinical evaluation and eventual clinical translation of this approach for epilepsy.SIGNIFICANCE STATEMENT Epilepsy is one of the most common neurological conditions, affecting millions of individuals of all ages. These patients experience debilitating seizures that frequently increase over time and can associate with significant cognitive decline and psychiatric disorders that are generally poorly controlled by pharmacotherapy. We have developed a clinically validated, implantable cell encapsulation system that delivers high and consistent levels of GDNF directly to the brain. In epileptic animals, this system produced a progressive and permanent reduction (>90%) in seizure frequency. These benefits were accompanied by improvements in cognitive and anxiolytic behavior and the normalization of changes in CNS anatomy that underlie chronic epilepsy. Together, these data suggest a novel means of tackling the frequently intractable neurological consequences of this devastating disorder.


Asunto(s)
Epilepsia/tratamiento farmacológico , Factor Neurotrófico Derivado de la Línea Celular Glial/administración & dosificación , Fármacos Neuroprotectores/administración & dosificación , Convulsiones/tratamiento farmacológico , Animales , Encapsulación Celular , Línea Celular , Sistemas de Liberación de Medicamentos/métodos , Epilepsia/inducido químicamente , Humanos , Masculino , Pilocarpina/administración & dosificación , Ratas Sprague-Dawley , Convulsiones/inducido químicamente
4.
Int J Mol Sci ; 21(3)2020 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-32019190

RESUMEN

Lymphoma, a group of widely prevalent hematological malignancies of lymphocyte origin, has become the focus of significant clinical research due to their high propensity for refractory/relapsed (R/R) disease, leading to poor prognostic outcomes. The complex molecular circuitry in lymphomas, especially in the aggressive phenotypes, has made it difficult to find a therapeutic option that can salvage R/R disease. Furthermore, the association of lymphomas with the Bone Marrow (BM) microenvironment has been found to portend worse outcomes in terms of heightened chances of relapse and acquired resistance to chemotherapy. This review assesses the current therapy options in three distinct types of lymphomas: diffuse large B-cell lymphoma, follicular lymphoma and mantle cell lymphoma. It also explores the role of the BM tumor microenvironment as a secure 'niche' for lymphoma cells to grow, proliferate and survive. It further evaluates potential mechanisms through which the tumor cells can establish molecular connections with the BM cells to provide pro-tumor benefits, and discusses putative therapeutic strategies for disrupting the BM-lymphoma cell communication.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Médula Ósea/patología , Resistencia a Antineoplásicos , Linfoma de Células B/patología , Microambiente Tumoral/inmunología , Médula Ósea/efectos de los fármacos , Médula Ósea/inmunología , Humanos , Linfoma de Células B/tratamiento farmacológico , Linfoma de Células B/inmunología , Microambiente Tumoral/efectos de los fármacos
5.
Epilepsy Behav ; 94: 124-130, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30909075

RESUMEN

OBJECTIVES: Children with temporal lobe epilepsy (TLE) exhibit executive dysfunction on traditional neuropsychological tests. There is limited evidence of different functional network alterations associated with this clinical executive dysfunction. This study investigates working memory deficits in children with TLE by assessing deactivation of the default mode network (DMN) on functional Magnetic Resonance Imaging (fMRI) and the relationship of DMN deactivation with fMRI behavioral findings and neuropsychological test performance. EXPERIMENTAL DESIGN: fMRI was conducted on 15 children with TLE and 15 healthy controls (age: 8-16 years) while performing the N-back task in order to assess deactivation of the DMN. N-back accuracy, N-back reaction time, and neuropsychological tests of executive function (Delis-Kaplan Executive Function System [D-KEFS] Color-Word Interference and Card Sort tests) were also assessed. PRINCIPAL OBSERVATIONS: During the N-back task, children with TLE exhibited significantly less deactivation of the DMN, primarily in the precuneus/posterior cingulate cortex compared with controls. These alterations significantly correlated with N-back behavioral findings and D-KEFS results. CONCLUSIONS: Children with TLE exhibit executive dysfunction which correlates with DMN alterations. These findings suggest that the level of deactivation of specific functional networks may contribute to cognitive impairment in children with TLE. The findings also indicate that children with TLE have network alterations in extratemporal lobe brain regions.


Asunto(s)
Encéfalo/fisiopatología , Epilepsia del Lóbulo Temporal/fisiopatología , Función Ejecutiva/fisiología , Memoria a Corto Plazo/fisiología , Adolescente , Encéfalo/diagnóstico por imagen , Niño , Disfunción Cognitiva/fisiopatología , Disfunción Cognitiva/psicología , Epilepsia del Lóbulo Temporal/diagnóstico por imagen , Epilepsia del Lóbulo Temporal/psicología , Femenino , Neuroimagen Funcional , Giro del Cíngulo/diagnóstico por imagen , Giro del Cíngulo/fisiopatología , Humanos , Imagen por Resonancia Magnética/métodos , Masculino , Pruebas Neuropsicológicas , Lóbulo Parietal/diagnóstico por imagen , Lóbulo Parietal/fisiopatología , Tiempo de Reacción
6.
Acta Neuropathol ; 133(6): 923-931, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-28332094

RESUMEN

Abnormal accumulation of TDP-43 into cytoplasmic or nuclear inclusions with accompanying nuclear clearance, a common pathology initially identified in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), has also been found in Alzheimer' disease (AD). TDP-43 serves as a splicing repressor of nonconserved cryptic exons and that such function is compromised in brains of ALS and FTD patients, suggesting that nuclear clearance of TDP-43 underlies its inability to repress cryptic exons. However, whether TDP-43 cytoplasmic aggregates are a prerequisite for the incorporation of cryptic exons is not known. Here, we assessed hippocampal tissues from 34 human postmortem brains including cases with confirmed diagnosis of AD neuropathologic changes along with age-matched controls. We found that cryptic exon incorporation occurred in all AD cases exhibiting TDP-43 pathology. Furthermore, incorporation of cryptic exons was observed in the hippocampus when TDP-43 inclusions was restricted only to the amygdala, the earliest stage of TDP-43 progression. Importantly, cryptic exon incorporation could be detected in AD brains lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43. These data supports the notion that the functional consequence of nuclear depletion of TDP-43 as determined by cryptic exon incorporation likely occurs as an early event of TDP-43 proteinopathy and may have greater contribution to the pathogenesis of AD than currently appreciated. Early detection and effective repression of cryptic exons in AD patients may offer important diagnostic and therapeutic implications for this devastating illness of the elderly.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/patología , Encéfalo/metabolismo , Encéfalo/patología , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/genética , Núcleo Celular/metabolismo , Núcleo Celular/patología , Estudios de Cohortes , Exones , Femenino , Humanos , Inmunohistoquímica , Masculino , Neuronas/metabolismo , Neuronas/patología , Proteinopatías TDP-43/metabolismo , Proteinopatías TDP-43/patología
7.
J Org Chem ; 80(15): 7530-5, 2015 Aug 07.
Artículo en Inglés | MEDLINE | ID: mdl-26153720

RESUMEN

Amine photobase generators (PBGs) are uncommon yet useful compounds. Rarer still are examples of PBGs that are active at visible wavelengths. We report the synthesis and characterization of new photolabile amine protecting groups that are active under visible light. The new chromophore, benzothiophene imino-phenylacetonitrile (BTIPA), was synthesized in four steps without use of chromatography and found to release any one of several amines upon exposure to 405 nm light. The chromophore was also demonstrated to be useful as a Merrifield synthesis protecting group. Experimental evidence suggests a sequential, two stage photolysis mechanism which leads to a nonlinear response to dose.

8.
CNS Oncol ; 13(1): 2375960, 2024 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-39039959

RESUMEN

Aim: Atypical teratoid rhabdoid tumor (ATRT) is a rare and highly aggressive primary CNS neoplasm, predominantly observed in children. The use of autologous stem cell transplantation (ASCT) in pediatric ATRT has shown promise; however, its utility in adult ATRT remains unclear. Patients & methods: This study presents the case of an adult patient with ATRT who is in remission after ASCT and reviews the literature on ASCT in adults with ATRT. Four cases of ATRT in adults who underwent ASCT were identified, with pertinent data summarized. Results: All five patients survived longer than the historical average survival rate, four of whom had no clinical or radiographic evidence of disease at the final follow-up. Conclusion: Based on limited data, there may be a role for ASCT in the treatment of adults with ATRT.


[Box: see text].


Asunto(s)
Tumor Rabdoide , Teratoma , Trasplante Autólogo , Humanos , Tumor Rabdoide/terapia , Tumor Rabdoide/patología , Tumor Rabdoide/cirugía , Adulto , Teratoma/terapia , Teratoma/patología , Teratoma/cirugía , Trasplante de Células Madre/métodos , Masculino , Femenino , Neoplasias Encefálicas/terapia , Neoplasias Encefálicas/patología , Neoplasias Encefálicas/cirugía
9.
medRxiv ; 2023 Sep 12.
Artículo en Inglés | MEDLINE | ID: mdl-37745408

RESUMEN

Background: Tau pathology is common in age-related neurodegenerative diseases. Tau pathology in primary age-related tauopathy (PART) and in Alzheimer's disease (AD) has a similar biochemical structure and anatomic distribution, which is distinct from tau pathology in other diseases. However, the molecular changes associated with intraneuronal tau pathology in PART and AD, and whether these changes are similar in the two diseases, is largely unexplored. Methods: Using GeoMx spatial transcriptomics, mRNA was quantified in CA1 pyramidal neurons with tau pathology and adjacent neurons without tau pathology in 6 cases of PART and 6 cases of AD, and compared to 4 control cases without pathology. Transcriptional changes were analyzed for differential gene expression and for coordinated patterns of gene expression associated with both disease state and intraneuronal tau pathology. Results: Synaptic gene changes and two novel gene expression signatures associated with intraneuronal tau were identified in PART and AD. Overall, gene expression changes associated with intraneuronal tau pathology were similar in PART and AD. Synaptic gene expression was decreased overall in neurons in AD and PART compared to control cases. However, this decrease was largely driven by neurons lacking tau pathology. Synaptic gene expression was increased in tau-positive neurons compared to tau-negative neurons in disease. Two novel gene expression signatures associated with intraneuronal tau were identified by examining coordinated patterns of gene expression. Genes in the up-regulated expression pattern were enriched in calcium regulation and synaptic function pathways, specifically in synaptic exocytosis. These synaptic gene changes and intraneuronal tau expression signatures were confirmed in a published transcriptional dataset of cortical neurons with tau pathology in AD. Conclusions: PART and AD show similar transcriptional changes associated with intraneuronal tau pathology in CA1 pyramidal neurons, raising the possibility of a mechanistic relationship between the tau pathology in the two diseases. Intraneuronal tau pathology was also associated with increased expression of genes associated with synaptic function and calcium regulation compared to tau-negative disease neurons. The findings highlight the power of molecular analysis stratified by pathology in neurodegenerative disease and provide novel insight into common molecular pathways associated with intraneuronal tau in PART and AD.

10.
Nat Chem ; 14(6): 632-639, 2022 06.
Artículo en Inglés | MEDLINE | ID: mdl-35655006

RESUMEN

The controlled isomerization and functionalization of alkenes is a cornerstone achievement in organometallic catalysis that is now widely used throughout industry. In particular, the addition of CO and H2 to an alkene, also known as the oxo-process, is used in the production of linear aldehydes from crude alkene feedstocks. In these catalytic reactions, isomerization is governed by thermodynamics, giving rise to functionalization at the most stable alkylmetal species. Despite the ubiquitous industrial applications of tandem alkene isomerization/functionalization reactions, selective functionalization at internal positions has remained largely unexplored. Here we report that the simple W(0) precatalyst W(CO)6 catalyses the isomerization of alkenes to unactivated internal positions and subsequent hydrocarbonylation with CO. The six- to seven-coordinate geometry changes that are characteristic of the W(0)/W(II) redox cycle and the conformationally flexible directing group are key factors in allowing isomerization to take place over multiple positions and stop at a defined unactivated internal site that is primed for in situ functionalization.


Asunto(s)
Alquenos , Tungsteno , Catálisis , Isomerismo , Oxidación-Reducción
11.
ACS Catal ; 12(19): 12369-12385, 2022 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-37215160

RESUMEN

Developing strategies to study reactivity and selectivity in flexible catalyst systems has become an important topic of research. Herein, we report a combined experimental and computational study aimed at understanding the mechanistic role of an achiral DABCOnium cofactor in a regio- and enantiodivergent bromocyclization reaction. It was found that electron-deficient aryl substituents enable rigidified transition states via an anion-π interaction with the catalyst, which drives the selectivity of the reaction. In contrast, electron-rich aryl groups on the DABCOnium result in significantly more flexible transition states, where interactions between the catalyst and substrate are more important. An analysis of not only the lowest-energy transition state structures but also an ensemble of low-energy transition state conformers via energy decomposition analysis and machine learning was crucial to revealing the dominant noncovalent interactions responsible for observed changes in selectivity in this flexible system.

12.
Pharm Res ; 28(5): 1074-80, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21225320

RESUMEN

PURPOSE: The prognosis for glioma patients is poor, and development of new treatments is critical. Previously, we engineered polymer-based vaccines that control GM-CSF, CpG-oligonucleotide, and tumor-lysate presentation to regulate immune cell trafficking and activation, which promoted potent immune responses against peripheral tumors. Here, we extend the use of this system to glioma. METHODS: Rats were challenged with an intracranial injection of glioma cells followed (1 week) by administration of the polymeric vaccine (containing GM-CSF, CpG, and tumor-lysate) in the tumor bed. Control rats were treated with blank matrices, matrices with GM-CSF and CpG, or intra-tumoral bolus injections of GM-CSF, CpG, and tumor lysate. Rats were monitored for survival and tested for neurological function. RESULTS: Survival studies confirmed a benefit of the polymeric vaccine as 90% of vaccinated rats survived for > 100 days. Control rats exhibited minimal benefit. Motor tests revealed that vaccination protected against the loss of forelimb use produced by glioma growth. Histological analysis quantitatively confirmed a robust and rapid reduction in tumor size. Long-term immunity was confirmed when 67% of survivors also survived a second glioma challenge. CONCLUSIONS: These studies extend previous reports regarding this approach to tumor therapy and justify further development for glioma treatment.


Asunto(s)
Neoplasias Encefálicas/terapia , Vacunas contra el Cáncer/uso terapéutico , Glioma/terapia , Inmunoterapia , Animales , Neoplasias Encefálicas/inmunología , Neoplasias Encefálicas/patología , Glioma/inmunología , Glioma/patología , Factor Estimulante de Colonias de Granulocitos y Macrófagos/inmunología , Factor Estimulante de Colonias de Granulocitos y Macrófagos/uso terapéutico , Humanos , Oligodesoxirribonucleótidos/inmunología , Oligodesoxirribonucleótidos/uso terapéutico , Ratas , Ratas Sprague-Dawley
13.
J Clin Neurophysiol ; 38(3): 221-225, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-32141985

RESUMEN

INTRODUCTION: Nonconvulsive seizures (NCSs) are common in critically ill adult patients with acute neurologic conditions. However, the effect of NCSs on patient outcome remains unclear. In this study, we aimed to determine the effect of NCSs on short-term outcome and to assess the clinical and EEG factors associated with NCSs. METHODS: We retrospectively identified 219 adult patients from the EEG reporting system who underwent continuous EEG (cEEG) monitoring between January 2018 and June 2018. Patients with anoxic brain injury were excluded from the study. Clinical, laboratory, and EEG data were reviewed to determine potentially predictive factors of NCSs. The impact of NCSs on in-hospital mortality, length of stay, and disability on discharge was measured; an modified Rankin scale of three or greater was considered disabled. RESULTS: Of the 219 patients included in our study, a total of 14% (n = 31) had NCSs on continuous EEG, of which 42% (n = 13) had their first seizure discharge recorded during the first hour of continuous EEG monitoring. The presence of clinical seizures before continuous EEG (odds ratio = 1.787; 95% confidence interval = 1.197-2.667, P = 0.0045), history of epilepsy (odds ratio = 1.508; 95% confidence interval = 1.027-2.215, P = 0.035), and comatose state (29 vs. 16%; P = 0.0006) were associated with NCSs. Among EEG characteristics, the presence of interictal epileptiform discharges (P < 0.0001), lateralized rhythmic delta activity (P = 0.02), and lateralized periodic discharges (P < 0.0001) were associated with NCSs. Nonconvulsive seizures were significantly associated with longer in-hospital stay (23.68 ± 24.84 vs. 17.14 ± 20.52; P = 0.036) and disability on discharge (87% [n = 27] vs. 13% [n = 4], P = 0.02). However, there was no significant association between NCS and in-hospital mortality (9.6% [n = 3] vs. 10.6% [n = 20]; P = 0.1). CONCLUSIONS: Nonconvulsive seizures are associated with longer in-hospital stay and disability on discharge but not with in-hospital mortality in adult patients.


Asunto(s)
Convulsiones/complicaciones , Adulto , Enfermedad Crítica , Electroencefalografía , Femenino , Mortalidad Hospitalaria , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Convulsiones/epidemiología
14.
Artículo en Inglés | MEDLINE | ID: mdl-33670135

RESUMEN

The human casualties from simulated nuclear detonation scenarios in New Delhi, India are analyzed, with a focus on the distribution of casualties in urban environments and the theoretical application of a nuclear-specific triage system with significant innovation in interdisciplinary disaster management applicable generally to urban nuclear detonation medical response. Model estimates of nuclear war casualties employed ESRI's ArcGIS 9.3, blast and prompt radiation were calculated using the Defense Nuclear Agency's WE program, and fallout radiation was calculated using the Defense Threat Reduction Agency's (DTRA's) Hazard Prediction and Assessment Capability (HPAC) V404SP4, as well as custom GIS and database software applications. ESRI ArcGISTM programs were used to calculate affected populations from the Oak Ridge National Laboratory's LandScanTM 2007 Global Population Dataset for areas affected by thermal, blast and radiation data. Trauma, thermal burn, and radiation casualties were thus estimated on a geographic basis for New Delhi, India for single and multiple (six) 25 kt detonations and a single 1 mt (1000 kt) detonation. Major issues related to the emergency management of a nuclear incident are discussed with specific recommendations for improvement. The consequences for health management of thermal burn and radiation patients is the worst, as burn patients require enormous resources to treat, and there will be little to no familiarity with the treatment of radiation victims. Of particular importance is the interdisciplinary cooperation necessary for such a large-scale emergency response event, which would be exemplified by efforts such as the application of a Nuclear Global Health Workforce.


Asunto(s)
Planificación en Desastres , Desastres , Explosiones , Humanos , India , Triaje
15.
Muscle Nerve ; 41(2): 262-4, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20082410

RESUMEN

Sprengel's deformity is the most common congenital deformity of the shoulder. A known complication of correcting this deformity is brachial plexus palsy. In this study we used somatosensory evoked potential (SSEP) monitoring during correction of a Sprengel's deformity and identified an early iatrogenic brachial plexus injury. The operation was modified, and permanent nerve injury was avoided. We recommend that SSEP monitoring be considered in procedures to correct Sprengel's deformity.


Asunto(s)
Plexo Braquial/fisiología , Potenciales Evocados Somatosensoriales/fisiología , Monitoreo Intraoperatorio/métodos , Osteotomía/métodos , Hombro/anomalías , Hombro/cirugía , Plexo Braquial/lesiones , Preescolar , Humanos , Masculino , Osteotomía/efectos adversos , Resultado del Tratamiento
16.
J Health Hum Serv Adm ; 33(3): 451-9, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21329195

RESUMEN

This special issue moves us forward in the discussion on disproportionality and disparate outcomes and in the identification and implementation of strategies and solutions. What is clear from this journal's articles is that addressing the disparities of children of color in foster care will require that we take an approach that is comprehensive and inclusive to allow us get to the root causes and create real sustainable change. This means we have to address the issue not only inside child welfare but across all systems and institutions that touch the lives of children and families; not only from the perspective of the child's well being but also from the perspective of the family's well being; and not only on the local level but also on the state and federal levels through policy change that aligns with our goals to keep all children safe by strengthening families. As the articles indicate, if we are to achieve any measure of success, we must build our efforts and strategies on a foundation that embraces and encourages an integrated response. Too often child welfare and other child-serving agencies address the needs of children on a very individual basis, outside the context of their families. That is the way the system is set up. However, to improve outcomes for all children, including children of color, we have to change our paradigm from that of child welfare to that of family well being, always seeing children in the context of their families; families in the context of their communities; and any intervention in the context of an integrated family and community support network. For example, addressing child neglect associated with poverty issues requires that we not only address the needs of that child or poor families, but we must also ultimately take actions to address the needs of the poor communities in which those children and families are trying to exist. Such an integrated response leads us to acknowledge the interconnectedness of children, families and their communities and to design strategies of intervention with an understanding that only when we address causative factors across each of these three spectrums (child, family, community) can we truly create the change we seek--improved outcomes for children of color--for all children--in or at risk of entering foster care.


Asunto(s)
Protección a la Infancia/etnología , Delincuencia Juvenil/etnología , Delincuencia Juvenil/prevención & control , Niño , Redes Comunitarias , Humanos , Grupos Minoritarios
17.
World Neurosurg ; 139: 583-587, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32360672

RESUMEN

BACKGROUND: Thermal coagulation is a central principle in surgery, particularly regarding hemostasis, as well as being an integral part of intracranial tumor removal. Traditionally, surgical hemostasis is achieved through application of unipolar or bipolar electrocautery. This method has been contemporized and specialized to treat intracranial tumors through a technique called stereotactic laser ablation (SLA), also known as laser interstitial thermal therapy. CASE DESCRIPTION: In this article, we present this technique as an additional option in the treatment of difficult intracranial tumors. Specifically, we report here a highly vascular and hemorrhagic pineocytoma found in a fragile, elderly patient who underwent a novel combination of procedures: SLA mediated devascularization followed by resection via an endoscopic approach. CONCLUSIONS: SLA-mediated thermal-coagulation is a potential strategy for minimizing hemorrhagic risks in brain tumor resection and may be used in conjunction with other approaches tailored to the patient and their disease.


Asunto(s)
Neoplasias Encefálicas/cirugía , Hemorragia Cerebral/cirugía , Terapia por Láser/métodos , Neuroendoscopía/métodos , Glándula Pineal/cirugía , Pinealoma/cirugía , Anciano , Neoplasias Encefálicas/diagnóstico por imagen , Hemorragia Cerebral/diagnóstico por imagen , Femenino , Humanos , Glándula Pineal/diagnóstico por imagen , Pinealoma/diagnóstico por imagen , Prueba de Estudio Conceptual
18.
Curr Res Pharmacol Drug Discov ; 1: 19-29, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-34909639

RESUMEN

Delivering glial cell line-derived neurotrophic factor (GDNF) to the brain is a potential treatment for Parkinson's Disease (PD). Here we use an implantable encapsulated cell technology that uses modified human clonal ARPE-19 â€‹cells to deliver of GDNF to the brain. In vivo studies demonstrated sustained delivery of GDNF to the rat striatum over 6 months. Anatomical benefits and behavioral efficacy were shown in 6-OHDA lesioned rats where nigral dopaminergic neurons were preserved in neuroprotection studies and dopaminergic fibers were restored in neurorecovery studies. When larger, clinical-sized devices were implanted for 3 months into the putamen of Göttingen minipigs, GDNF was widely distributed throughout the putamen and caudate producing a significant upregulation of tyrosine hydroxylase immunohistochemistry. These results are the first to provide clear evidence that implantation of encapsulated GDNF-secreting cells deliver efficacious and biologically relevant amounts of GDNF in a sustained and targeted manner that is scalable to treat the large putamen in patients with Parkinson's disease.

19.
Clin Cancer Res ; 14(11): 3462-9, 2008 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-18519778

RESUMEN

PURPOSE: Interleukin-18 (IL-18) is an immunostimulatory cytokine with antitumor activity in preclinical models. A phase I study of recombinant human IL-18 (rhIL-18) was done to determine the toxicity, pharmacokinetics, and biological activities of rhIL-18 administered at different doses in two different schedules to patients with advanced cancer. EXPERIMENTAL DESIGN: Cohorts of three to four patients were given escalating doses of rhIL-18 as a 2-h i.v. infusion either on 5 consecutive days repeated every 28 days (group A) or once a week (group B) for up to 6 months. Toxicities were graded using standard criteria. Blood samples were obtained for safety, pharmacokinetic, and pharmacodynamic measurements. RESULTS: Nineteen patients (10 melanoma and 9 renal cell cancer) were given rhIL-18 in doses of 100, 500, or 1,000 microg/kg (group A) or 100, 1,000, or 2,000 microg/kg (group B). Common side effects included chills, fever, headache, fatigue, and nausea. Common laboratory abnormalities included transient, asymptomatic grade 1 to 3 lymphopenia, grade 1 to 4 hyperglycemia, grade 1 to 2 anemia, neutropenia, hypoalbuminemia, liver enzyme elevations, and serum creatinine elevations. No dose-limiting toxicities were observed. Biological effects of rhIL-18 included transient lymphopenia and increased expression of activation antigens on lymphocytes. Increases in serum concentrations of IFN-gamma, granulocyte macrophage colony-stimulating factor, and IL-18-binding protein were observed following dosing. CONCLUSIONS: rhIL-18 can be given in biologically active doses by either weekly infusions or daily infusions for 5 days repeated every 28 days to patients with advanced cancer. Toxicity was generally mild to moderate, and a maximum tolerated dose of rhIL-18 by either schedule was not determined.


Asunto(s)
Antineoplásicos/administración & dosificación , Interleucina-18/administración & dosificación , Neoplasias/tratamiento farmacológico , Proteínas Recombinantes/administración & dosificación , Anciano , Anticuerpos/sangre , Antineoplásicos/inmunología , Antineoplásicos/farmacocinética , Esquema de Medicación , Femenino , Humanos , Interleucina-18/inmunología , Interleucina-18/farmacocinética , Masculino , Dosis Máxima Tolerada , Persona de Mediana Edad , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/farmacocinética
20.
Age Ageing ; 38(3): 271-6; discussion, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19252208

RESUMEN

BACKGROUND: pyogenic liver abscess (PLA) is a potentially life-threatening disease in middle-to-old aged persons. OBJECTIVE: to compare the differences in clinical features and outcomes between older and younger PLA patients, and to identify predictors of outcomes in older patients. DESIGN: retrospective chart review of all PLA patients between July 1999 and June 2007. SETTING: a 1,600-bed primary and tertiary care centre. SUBJECTS: in total, 339 patients were enrolled and included 118 > or =65 years of age (the elderly group) and 221 patients <65 years of age (the non-elderly group). METHODS: clinical features, laboratory, imaging and microbiologic findings, treatment and outcomes for each of the included patients were collected. The predictor of outcome was determined using logistic regression and purposeful selection of covariates. RESULTS: the elderly group had a higher APACHE II score on admission, a biliary abnormality, a malignancy, a pleural effusion, polymicrobial, anaerobic or multi-drug-resistant isolates, inappropriate initial antibiotics, a longer hospitalisation and a longer parenteral antibiotic treatment period than the non-elderly group, whereas the non-elderly group was more likely to be alcoholic men with cryptogenic origin of abscess and Klebsiella pneumoniae infection. There was no difference in case fatality between the elderly (13.6%) and non-elderly (8.6%) groups despite the elderly group having a poorer host status on admission. In multivariate analysis, age (P = 0.028) and APACHE II score at admission > or =15 (P = 0.001) were risk factors, but K. pneumoniae infection (P = 0.012) was a protective factor for fatality in older PLA patients. CONCLUSIONS: these data suggest that older PLA patients would have a fair outcome compared to younger patients, but require longer hospitalisations.


Asunto(s)
Absceso Piógeno Hepático , APACHE , Adulto , Factores de Edad , Anciano , Antibacterianos/uso terapéutico , Procedimientos Quirúrgicos del Sistema Digestivo , Drenaje/métodos , Femenino , Humanos , Tiempo de Internación , Absceso Piógeno Hepático/diagnóstico , Absceso Piógeno Hepático/etiología , Absceso Piógeno Hepático/mortalidad , Absceso Piógeno Hepático/terapia , Modelos Logísticos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Succión , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA